{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T09:19:26Z","timestamp":1775899166112,"version":"3.50.1"},"reference-count":28,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2017,6,26]],"date-time":"2017-06-26T00:00:00Z","timestamp":1498435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Clinical and Translational Science Center at Weill Cornell Medicine","award":["UL1-TR000457"],"award-info":[{"award-number":["UL1-TR000457"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis Care &amp;amp; Research"],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To determine if a cardiovascular disease (CVD) prevention counseling program for lupus patients decreases the prevalence of CVD risk factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The assessment phase of a 3\u2010year CVD prevention counseling program included the evaluation of CVD risk factors, diet, exercise habits, and medications. The education phase included discussion of the above risk factors, as well as CVD and thrombosis prevention strategies. Patients were prospectively followed every 3\u20136 months for risk assessment and continued education by a nurse practitioner and a medical doctor.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Between March 2009 and December 2014, 121 patients were included. At baseline, abnormal blood pressure, blood glucose, cholesterol profile, and body mass index were found in 50 (41%), 7 (6%), 82 (68%), and 77 (64%) patients, respectively. During the 3\u2010year followup, among those with abnormal baseline values, prevalence of abnormal blood pressure significantly decreased (odds ratio [OR] 0.94, 95% confidence interval [95% CI] 0.92\u20130.96, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) with significant mean\u2009\u00b1\u2009SD systolic blood pressure improvement (\u22126.12\u2009\u00b1\u20092.16 mm Hg; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The prevalence of abnormal cholesterol profile significantly decreased (OR 0.90, 95% CI 0.92\u20130.96) with significant improvements in mean\u2009\u00b1\u2009SD high\u2010density lipoprotein (+5.4\u2009\u00b1\u20090.36 mg\/dl; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) and triglyceride levels (\u221212.6\u2009\u00b1\u20095.40 mg\/dl; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05), and no significant change in blood glucose and body mass index was observed. At baseline, 100 (83%) and 95 (79%) patients had poor diet and physical activity, respectively; during the followup, both significantly improved in the entire population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our data suggest that a CVD prevention counseling program decreases the prevalence of some CVD risk factors in lupus patients.<\/jats:p><\/jats:sec>","DOI":"10.1002\/acr.23128","type":"journal-article","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T00:03:22Z","timestamp":1476662602000},"page":"1209-1216","source":"Crossref","is-referenced-by-count":12,"title":["Cardiovascular Disease Prevention Counseling Program for Systemic Lupus Erythematosus Patients"],"prefix":"10.1002","volume":"69","author":[{"given":"C\u00e9cile M.","family":"Yelnik","sequence":"first","affiliation":[{"name":"University of Lille Lille France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Richey","sequence":"additional","affiliation":[{"name":"Barbara Volcker Center for Women and Rheumatic Diseases, Hospital for Special Surgery, Weill Cornell Medicine New York New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Haiduc","sequence":"additional","affiliation":[{"name":"Barbara Volcker Center for Women and Rheumatic Diseases, Hospital for Special Surgery, Weill Cornell Medicine New York New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotiria","family":"Everett","sequence":"additional","affiliation":[{"name":"Population and Preventive Medicine, Stony Brook University Stony Brook New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Barbara Volcker Center for Women and Rheumatic Diseases, Hospital for Special Surgery, Weill Cornell Medicine New York New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doruk","family":"Erkan","sequence":"additional","affiliation":[{"name":"Barbara Volcker Center for Women and Rheumatic Diseases, Hospital for Special Surgery, Weill Cornell Medicine New York New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,6,26]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128920"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21955"},{"key":"e_1_2_7_4_1","first-page":"713","article-title":"Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964\u201395","volume":"31","author":"Bj\u00f6rn\u00e5dal L","year":"2004","journal-title":"J Rheumatol"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314551083"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314543919"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22367"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(92)90578-Y"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01753.x"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315582284"},{"key":"e_1_2_7_12_1","first-page":"32","article-title":"Prevalence of and risk factors for the metabolic syndrome in women with systemic lupus erythematosus","volume":"26","author":"Bultink IE","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315603140"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2014.06.018"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22593"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCN.0b013e31827f0d53"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-011-1747-9"},{"key":"e_1_2_7_18_1","first-page":"493","article-title":"Cardiovascular risk factor screening in systemic lupus erythematosus","volume":"30","author":"Al\u2010Herz A","year":"2003","journal-title":"J Rheumatol"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2009.03.005"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23419"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2013.04.003"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep037"},{"key":"e_1_2_7_23_1","first-page":"S791","article-title":"The health improvement and prevention program (HIPP) in systemic lupus erythematosus (SLE) shows preliminary benefits in reducing the estimated 8\u2010year risk of cardiovascular disease [abstract]","volume":"54","author":"Fortin PR","year":"2006","journal-title":"Arthritis Rheum"},{"key":"e_1_2_7_24_1","article-title":"Targeted coronary heart disease (CHD) risk factor management in SLE: Results from a dedicated nurse\u2010led clinic [abstract]","author":"Adimulam SB","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/94.1.19"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203312436854"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(76)90431-9"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.11.1066"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.113696"}],"container-title":["Arthritis Care &amp; Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Facr.23128","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Facr.23128","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acr.23128","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/acr.23128","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acr.23128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T16:23:38Z","timestamp":1759422218000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/acr.23128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,26]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1002\/acr.23128"],"URL":"https:\/\/doi.org\/10.1002\/acr.23128","archive":["Portico"],"relation":{},"ISSN":["2151-464X","2151-4658"],"issn-type":[{"value":"2151-464X","type":"print"},{"value":"2151-4658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,26]]}}}